HOME >> BIOLOGY >> NEWS
Breast cancer prognosis runs in the family

The chances of developing breast cancer are to some extent inherited, but important new findings suggest survival also runs in the family. Research published in the online journal Breast Cancer Research suggests that if a woman succumbs to breast cancer her daughters or sisters are over 60 percent more likely to die within five years if they develop the disease.

Mikael Hartman from the Karolinska Institute in Stockholm, Sweden led an international team, identifying 2,787 mother-daughter pairs and 831 sister pairs among women with breast cancer diagnosed between 1961 and 2001 from Swedens national Multi-Generation Register.

They found that a womans breast cancer prognosis predicts the survival of her first-degree relatives with breast cancer. Mothers surviving breast cancer after five years, had daughters with a 91 percent chance of surviving the disease. But only 87 percent of daughters whose mothers had died within five years survived. Being sister to a woman who had died of breast cancer within five years gave a 70 percent chance of survival from breast cancer, whereas chances improved to 88 percent if she had survived. Overall, a poor prognosis for a woman gave first-degree relatives a 60-80 percent higher chance of breast cancer mortality within the five-year timeframe.

Access to health care in Sweden is good irrespective of socio-economic status, so these factors are unlikely to have biased the findings. Women with a mother or sister who has had breast cancer are also likely to be more aware of the disease, making delays in seeking treatment unlikely. As well as genetics, other risk factors such as obesity and hormone replacement therapy probably play a role in the incidence and outcome of breast cancer. Dr Hartman says the findings are relevant to women with newly diagnosed breast cancer, and to those treating them. The next step will be to understand what is inherited; tumor biology, response to therapy or vigilance of the im
'"/>

Contact: Charlotte Webber
press@biomedcentral.com
44-020-763-19980
BioMed Central
28-Jun-2007


Page: 1 2

Related biology news :

1. Breast cancer and hormone therapy -- A looking-glass mirror?
2. Breast cancer milieu -- Progression, tamoxifen sensitivity, and DNA reversion
3. Is bigger better? Breast surgery linked to boost in self-esteem and sexuality
4. Breast cancer treatment heats up
5. Genesearch Breast Lymph Node assay detects breast cancer metastases with greater sensitivity
6. Breast Cancer Month story tips from Georgetown University Medical Center
7. Breast density helps predict breast cancer risk
8. Breast stem cells have features similar to basal tumors
9. Breast cancer genetics and more -- press release from PLoS Medicine
10. Breast-sparing surgery an option for women with breast cancer gene mutation, U-M-led study finds
11. Breast implants not associated with cancer risk, study reports

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/21/2019)... CONSHOHOCKEN, Pa. (PRWEB) , ... May 21, 2019 , ... ... trial randomization and drug supply chain management, has been named one of Inc. Magazine’s ... , The full list , now featured on Inc.com and hitting the newsstands ...
(Date:5/21/2019)... ... May 21, 2019 , ... At their May 16 ... Tissue Engineered Medical Products (TEMPs) of the American Society for Testing and Materials ... Gaining this approval was the next step in the company’s plan to establish ...
(Date:5/14/2019)... (PRWEB) , ... May 13, 2019 , ... ... Tuesday, June 4th, at a very special Pre-EWMA 2019 event at Gothenburg’s Universeum ... the latest Trends, Opportunities and Innovations in Advanced Wound Care. , SmartTRAK’s Advanced ...
Breaking Biology News(10 mins):
(Date:4/16/2019)... ... April 16, 2019 , ... ... their project partner, the U.S. Army Center for Environmental Health Research (USACEHR), with ... Combined In-Licensing/Out-Licensing.” , Blue Sources, a veteran-owned company located at the Frederick Innovative ...
(Date:4/15/2019)... ... 15, 2019 , ... Sirrus, Inc., a developer of novel ... expansion to increase production of methylene malonate monomers and oligomers. , The expanded ... full-scale production facility, which is scheduled to break ground in 2019. “The expanded ...
(Date:4/10/2019)... ... April 10, 2019 , ... ... have locked into multiple agreements to help companies advance their innovations to ... industry, ranging from synthetic biology companies that are gene editing therapeutic cells ...
(Date:4/9/2019)... , ... April 09, 2019 , ... ... focused on increasing the capacity of life sciences organizations to accelerate innovation and ... Assurance platform in the past 12 months. , USDM’s Cloud Assurance ...
Breaking Biology Technology:
Cached News: